Stock LKL LKL INTERNATIONAL
Add to a list
To use this feature you must be a member
Log inSign up

Financials LKL International

Equities

LKL

MYQ0182OO004

Medical Equipment, Supplies & Distribution

End-of-day quote BURSA MALAYSIA
Other stock markets
 06:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
0.12 MYR 0.00% Intraday chart for LKL International +4.35% -17.24%
Feb. 29 LKL International Berhad Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 CI
2023 LKL International Berhad Announces Termination of Memorandum of Understanding with Serv Medical Pte. Ltd CI

Valuation

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization 1 87.9 47.17 57.89 433.1 54.64 36.92
Enterprise Value (EV) 1 72.98 41.94 52.82 438 -19.13 20.2
P/E ratio 19.5 x -42.3 x -23.2 x 91.5 x -0.95 x -2.15 x
Yield 1.71% - - - - -
Capitalization / Revenue 2.59 x 1.59 x 1.56 x 7.88 x 1.03 x 0.45 x
EV / Revenue 2.15 x 1.41 x 1.42 x 7.97 x -0.36 x 0.25 x
EV / EBITDA 11.1 x 40.1 x -90.5 x 65.2 x 2.42 x -1.06 x
EV / FCF -15.8 x -4.49 x 47.1 x -45.9 x - -
FCF Yield -6.33% -22.3% 2.12% -2.18% - -
Price to Book 1.47 x 0.8 x 1.03 x 6.49 x 0.4 x 0.28 x
Nbr of stocks (in thousands) 42,880 42,880 42,880 47,334 78,060 97,160
Reference price 2 2.050 1.100 1.350 9.150 0.7000 0.3800
Announcement Date 8/30/17 8/30/18 8/30/19 8/28/20 1/31/22 4/28/23
1MYR in Million2MYR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales 1 33.89 29.72 37.18 54.95 53.3 81.98
EBITDA 1 6.591 1.046 -0.5838 6.722 -7.903 -19.06
EBIT 1 5.255 -0.7366 -2.564 5.151 -9.591 -20.8
Operating Margin 15.51% -2.48% -6.9% 9.37% -17.99% -25.37%
Earnings before Tax (EBT) 1 6.052 -1.202 -2.885 5.568 -36.72 -17.11
Net income 1 4.479 -1.098 -2.497 4.297 -36.44 -16.32
Net margin 13.22% -3.7% -6.72% 7.82% -68.38% -19.91%
EPS 2 0.1050 -0.0260 -0.0582 0.1000 -0.7334 -0.1764
Free Cash Flow 1 -4.621 -9.338 1.122 -9.538 - -
FCF margin -13.63% -31.42% 3.02% -17.36% - -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share 2 0.0350 - - - - -
Announcement Date 8/30/17 8/30/18 8/30/19 8/28/20 1/31/22 4/28/23
1MYR in Million2MYR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 - - - 4.93 - -
Net Cash position 1 14.9 5.23 5.07 - 73.8 16.7
Leverage (Debt/EBITDA) - - - 0.7331 x - -
Free Cash Flow 1 -4.62 -9.34 1.12 -9.54 - -
ROE (net income / shareholders' equity) 9.44% -2.24% -4.99% 7.82% - -
ROA (Net income/ Total Assets) 5.27% -0.64% -2.25% 4.32% - -
Assets 1 84.91 172.6 111 99.53 - -
Book Value Per Share 2 1.390 1.370 1.310 1.410 1.760 1.340
Cash Flow per Share 2 0.4200 0.2000 0.2000 0.1200 0.8500 0.1500
Capex 1 6.89 6.42 0.54 1.58 9.12 15
Capex / Sales 20.34% 21.62% 1.46% 2.88% 17.11% 18.35%
Announcement Date 8/30/17 8/30/18 8/30/19 8/28/20 1/31/22 4/28/23
1MYR in Million2MYR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
LKL INTERNATIONAL Stock LKL International
-17.24% 9.77M
ABBOTT LABORATORIES Stock Abbott Laboratories
-2.31% 187B
MEDTRONIC PLC Stock Medtronic plc
-3.20% 106B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-5.04% 66.9B
DEXCOM, INC. Stock DexCom, Inc.
+0.20% 49.45B
CENCORA, INC. Stock Cencora, Inc.
+17.29% 48B
HOYA CORPORATION Stock Hoya Corporation
+4.06% 40.84B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+2.07% 26.48B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+2.36% 26.25B
TERUMO CORPORATION Stock Terumo Corporation
+12.96% 24.62B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. LKL Stock
  4. Financials LKL International